BA
Bhavini Arawattigi
About Bhavini Arawattigi
Data last updated:
Bhavini Arawattigi is a Director at Sevda Pharmaceuticals Private Limited (since 2021) and Designated Partner at Sevda Clinics Llp (since 2023). The companies operate in Healthcare. The largest current company by reported revenue is Sevda Pharmaceuticals Private Limited at ₹18.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sevda Pharmaceuticals Private Limited U51909GA2018PTC013480 | Director | 16 Jul 2021 | 2018 | ₹18.2 Lakh (FY 2024) | Active |
| Sevda Clinics Llp ACC-8886 | Designated Partner | 21 Nov 2023 | 2023 | Active |
Board colleagues of Bhavini Arawattigi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suyog Samuel Arawattigi | 06634451 | Sevda Pharmaceuticals Private Limited , Sevda Clinics Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhavini Arawattigi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhavini Arawattigi
Bhavini Arawattigi currently holds 2 directorships: Sevda Pharmaceuticals Private Limited (Director, since 16 Jul 2021, revenue ₹18.2 Lakh (FY 2024)); Sevda Clinics Llp (Designated Partner, since 21 Nov 2023).
Bhavini Arawattigi was first appointed on 16 Jul 2021 as Director at Sevda Pharmaceuticals Private Limited. The most recent appointment on record is 21 Nov 2023 at Sevda Clinics Llp.
The current boards of Bhavini Arawattigi's companies include Suyog Samuel Arawattigi (Sevda Pharmaceuticals Private Limited).